Abd-Nikfarjam B, Dolati-Somarin A, Baradaran Rahimi V et al (2023) Cannabinoids in neuroinflammatory disorders: focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases. BioFactors. https://doi.org/10.1002/biof.1936

Article  PubMed  Google Scholar 

Abush H, Akirav I (2010) Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20(10):1126–1138

Article  CAS  PubMed  Google Scholar 

Acheson SK, Moore NL, Kuhn CM et al (2011) The synthetic cannabinoid WIN 55212–2 differentially modulates thigmotaxis but not spatial learning in adolescent and adult animals. Neurosci Lett 487(3):411–414

Article  CAS  PubMed  Google Scholar 

Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13(2):93–110

Article  CAS  PubMed  Google Scholar 

Aso E, Palomer E, Juves S et al (2012) CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AbetaPP/PS1 mice. J Alzheimers Dis 30(2):439–459

Article  CAS  PubMed  Google Scholar 

Balderas I, Rodriguez-Ortiz CJ, Bermudez-Rattoni F (2013) Retrieval and reconsolidation of object recognition memory are independent processes in the perirhinal cortex. Neuroscience 253:398–405

Article  CAS  PubMed  Google Scholar 

Batalla A, Bhattacharyya S, Yucel M et al (2013) Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS ONE 8(2):e55821

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergamaschi MM, Queiroz RHC, Chagas MHN et al (2011) Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 36(6):1219–1226

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bilkei-Gorzo A, Albayram O, Draffehn A et al (2017) A chronic low dose of Delta(9)-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nat Med 23(6):782–787

Article  CAS  PubMed  Google Scholar 

Block RI, O’Leary DS, Hichwa RD et al (2000) Cerebellar hypoactivity in frequent marijuana users. NeuroReport 11(4):749–753

Article  CAS  PubMed  Google Scholar 

Bourin M, Hascoet M (2003) The mouse light/dark box test. Eur J Pharmacol 463(1–3):55–65

Article  CAS  PubMed  Google Scholar 

Bouter C, Henniges P, Franke TN et al (2018) 18F-FDG-PET detects drastic changes in brain metabolism in the Tg4-42 model of Alzheimer’s disease. Front Aging Neurosci 10:425

Article  CAS  PubMed  Google Scholar 

Bouter C, Irwin C, Franke TN et al (2021) Quantitative brain positron emission tomography in female 5XFAD Alzheimer mice: pathological features and sex-specific alterations. Front Med (lausanne) 8:745064

Article  PubMed  Google Scholar 

Brook JS, Lee JY, Finch SJ et al (2013) Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Subst Abus 34(3):298–305

Article  PubMed  PubMed Central  Google Scholar 

Burnett GM, Gorelick DA, Hill KP (2022) Policy ahead of the science: medical cannabis laws versus scientific evidence. Psychiatr Clin North Am 45(3):347–373

Article  PubMed  Google Scholar 

Cadoni C, Valentini V, Di Chiara G (2008) Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. J Neurochem 106(4):1586–1593

Article  CAS  PubMed  Google Scholar 

Cassar D, Radic M, Casarrubea M et al (2022) The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze. CNS Neurosci Ther 28(8):1268–1270

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cha YM, White AM, Kuhn CM et al (2006) Differential effects of delta9-THC on learning in adolescent and adult rats. Pharmacol Biochem Behav 83(3):448–455

Article  CAS  PubMed  Google Scholar 

Chang L, Chronicle EP (2007) Functional imaging studies in cannabis users. Neuroscientist 13(5):422–432

Article  PubMed  Google Scholar 

Chen X, Zhang J, Chen C (2011) Endocannabinoid 2-arachidonoylglycerol protects neurons against beta-amyloid insults. Neuroscience 178:159–168

Article  CAS  PubMed  Google Scholar 

Cohen K, Kapitany-Foveny M, Mama Y et al (2017) The effects of synthetic cannabinoids on executive function. Psychopharmacology 234(7):1121–1134

Article  CAS  PubMed  Google Scholar 

Cohen K, Mama Y, Rosca P et al (2020) Chronic use of synthetic cannabinoids is associated with impairment in working memory and mental flexibility. Front Psychiatry 11:602

Article  PubMed  PubMed Central  Google Scholar 

Coleman RA, Liang C, Patel R et al (2017) Brain and brown adipose tissue metabolism in transgenic Tg2576 mice models of alzheimer disease assessed using 18F-FDG PET imaging. Mol Imaging 16:1536012117704557

Article  PubMed  PubMed Central  Google Scholar 

Connor JP, Stjepanovic D, Le Foll B et al (2021) Cannabis use and cannabis use disorder. Nat Rev Dis Primers 7(1):16

Article  PubMed  PubMed Central  Google Scholar 

Cooke MB, O’Leary TP, Harris P et al (2019) Pathfinder: open source software for analyzing spatial navigation search strategies. F1000Res 8:1521

Article  PubMed  Google Scholar 

Cooray R, Gupta V, Suphioglu C (2020a) Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson’s and Alzheimer’s diseases: a review. Mol Neurobiol 57(11):4878–4890

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cooray R, Gupta V, Suphioglu C (2020b) Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson’s and Alzheimer’s diseases: a review. Mol Neurobiol. https://doi.org/10.1007/s12035-020-02054-6

Article  PubMed  PubMed Central  Google Scholar 

Cupo L, Plitman E, Guma E et al (2021) A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis. Transl Psychiatry 11(1):217

Article  PubMed  PubMed Central  Google Scholar 

Curdt N, Schmitt FW, Bouter C et al (2022) Search strategy analysis of Tg4-42 Alzheimer mice in the Morris water maze reveals early spatial navigation deficits. Sci Rep 12(1):5451

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dere E, Huston JP, De Souza Silva MA (2007) The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 31(5):673–704

Article  CAS  PubMed  Google Scholar 

Dutta S, Sengupta P (2016) Men and mice: relating their ages. Life Sci 152:244–248

Article  CAS  PubMed  Google Scholar 

Ehrenreich H, Rinn T, Kunert HJ et al (1999) Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology 142(3):295–301

Article  CAS  PubMed  Google Scholar 

Eldreth DA, Matochik JA, Cadet JL et al (2004) Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage 23(3):914–920

Article  PubMed  Google Scholar 

Esposito G, Scuderi C, Savani C et al (2007) Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br J Pharmacol 151(8):1272–1279

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feingold D, Weinstein A (2021) Cannabis and depression. Adv Exp Med Biol 1264:67–80

Article  CAS  PubMed  Google Scholar 

Fischer AS, Tapert SF, Lee Louie D et al (2020) Cannabis and the developing adolescent brain. Curr Treat Options Psychiatry 7(2):144–161

Article  PubMed  PubMed Central  Google Scholar 

Fouda MA, Fathy Mohamed Y, Fernandez R et al (2022) Anti-inflammatory effects of cannabidiol against lipopolysaccharides in cardiac sodium channels. Br J Pharmacol. https://doi.org/10.1111/bph.15936

Article  PubMed  Google Scholar 

Franke TN, Irwin C, Bayer TA et al (2020) In vivo imaging with 18F-FDG- and 18F-Florbetaben-PET/MRI detects pathological changes in the brain of the commonly used 5XFAD mouse model of Alzheimer’s disease. Front Med (Lausanne) 7:529